uniQure
QURE
$4.53
Share price
-0.22%
Change (1 day)
-76.58%
Change (1 year)
Market capitalization of uniQure (QURE)
Market cap: $0.21 Billion
As of April 2024 uniQure has a market cap of $0.21 Billion. This makes uniQure the world's 6858th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of uniQure from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.21 B | -33.05% |
| 2023 | $0.32 B | -69.5% |
| 2022 | $1.06 B | 10.73% |
| 2021 | $0.95 B | -40.38% |
| 2020 | $1.60 B | -48.68% |
| 2019 | $3.13 B | 190.99% |
| 2018 | $1.07 B | 78.41% |
| 2017 | $0.60 B | 328.64% |
| 2016 | $0.14 B | -65.02% |
| 2015 | $0.40 B | 50.23% |
| 2014 | $0.26 B |
End of Day market cap according to different sources
On Apr 26th, 2024 the market cap of uniQure was reported to be:
$0.21 Billion
$0.21 Billion
$0.21 Billion
$0.21 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $144.81 B | 66,723.16% | 🇺🇸 USA |
 Sanofi SNY | $122.65 B | 56,497.30% | 🇫🇷 France |
 Sangamo Therapeutics
SGMO | $0.10 B | -50.42% | 🇺🇸 USA |
 bluebird bio
BLUE | $0.17 B | -17.93% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $15.35 B | 6,985.52% | 🇺🇸 USA |
 Avidity Biosciences RNA | $1.94 B | 796.12% | 🇺🇸 USA |